Methyl (2Z)-4-[(1R,2R,8S,17R,19S)-12-hydroxy-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-16-(morpholin-4-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4,6(11),9,12-tetraen-19-yl]-2-methylbut-2-enoate
Structure Info
- Chemspace ID
- CSSB02125555353 (In-Stock Building Blocks)
- MFCD
- MFCD28064340
- IUPAC Name
- methyl (2Z)-4-[(1R,2R,8S,17R,19S)-12-hydroxy-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-16-(morpholin-4-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4,6(11),9,12-tetraen-19-yl]-2-methylbut-2-enoate
- Mol formula
- C43H55NO9
- Mol weight
- 730 Da
- Catalog Number(s)
- AGN-PC-0WR23U, BBLS02125555353, BD00847936, BP-22469, LN05089128, Y3513716, bbls02125555353
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 7.73
- Heavy atoms count
- 53
- Rotatable bond count
- 10
- Number of rings
- 7
- Carbon bond saturation, Fsp3
- 0.604
- Polar surface area (Å)
- 121
- Hydrogen bond acceptors count
- 9
- Hydrogen bond donors count
- 1
![Chemical structure of Methyl (2Z)-4-[(1R,2R,8S,17R,19S)-12-hydroxy-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-16-(morpholin-4-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4,6(11),9,12-tetraen-19-yl]-2-methylbut-2-enoate (C43H55NO9) - CSSB02125555353](/st/structure/200/115ccf240d68a301c61fe7235463ad68/COC%2528%253DO%2529C%2528%255CC%2529%253DC%252FC%255BC%2540%255D12OC%2528C%2529%2528C%2529%255BC%2540H%255D3C%255BC%2540H%255D%2528C%2528C4C%2528%253DO%2529C5%253DC%2528O%2529C6%253DC%2528O%255BC%2540%2540%255D%2528C%2529%2528CCC%253DC%2528C%2529C%2529C%253DC6%2529C%2528CC%253DC%2528C%2529C%2529%253DC5O%255BC%2540%255D134%2529N1CCOCC1%2529C2%253DO.png "C43H55NO9")
- Zoom the structure
- CSSB02125555353
Items Overall 8 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BB4LS US | 5 days | United States To: | 90 | 50 umol | 374.22 | |
| BB4LS US | 5 days | United States To: | 90 | 100 umol | 381.15 | |
| BB4LS US | 5 days | United States To: | 90 | 200 umol | 388.08 | |
| BB4LS US | 5 days | United States To: | 90 | 300 umol | 395.01 | |
| BB4LS US | 5 days | United States To: | 90 | 500 umol | 401.94 | |
| Broadpharm | 20 days | United States To: | 90 | 500 mg | 385.00 | |
| Broadpharm | 20 days | United States To: | 90 | 1 g | 748.00 | |
| Broadpharm | 20 days | United States To: | 90 | 5 g | 2,530.00 | |
Description: Morpholinyl methyl gambogate; CAS: 1951430-58-2 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of (2Z)-4-[(1S,2S,8R,15S,16S,17S,19R)-12-hydroxy-16-methoxy-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4,6(11),9,12-tetraen-19-yl]-2-methylbut-2-enoic acid - CSSB06744597291](/st/structure/200/f90c8c5a503baad1dd70db9933f95a69/CO%255BC%2540H%255D1%255BC%2540%2540H%255D2C%255BC%2540H%255D3C%2528C%2529%2528C%2529O%255BC%2540%2540%255D%2528C%255CC%253DC%2528%255CC%2529C%2528O%2529%253DO%2529%2528C2%253DO%2529%255BC%2540%255D32Oc3c%2528CC%253DC%2528C%2529C%2529c4O%255BC%2540%255D%2528C%2529%2528CCC%253DC%2528C%2529C%2529C%253DCc4c%2528O%2529c3C%2528%253DO%2529%255BC%2540%2540H%255D12.png)
![Chemical structure of (2Z)-4-[(1S,2S,8S,15S,16S,17S,19R)-12,16-dihydroxy-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11-tetraen-19-yl]-2-methylbut-2-enoic acid - CSSB06744480102](/st/structure/200/111db75424c762a1371f86435f4745de/CC%2528C%2529%253DCCC%255BC%2540%255D1%2528C%2529Oc2c%2528CC%253DC%2528C%2529C%2529c3O%255BC%2540%2540%255D45%255BC%2540H%255D6C%255BC%2540%2540H%255D%2528%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D4C%2528%253DO%2529c3c%2528O%2529c2C%253DC1%2529C%2528%253DO%2529%255BC%2540%255D5%2528C%255CC%253DC%2528%255CC%2529C%2528O%2529%253DO%2529OC6%2528C%2529C.png)
![Chemical structure of (2E)-4-[(1S,2S,15R,19R)-12-hydroxy-16-methoxy-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4,6(11),9,12-tetraen-19-yl]-2-(hydroxymethyl)but-2-enoic acid - CSSB14945382378](/st/structure/200/54d7c0a4c9803afa526e5fc9a1bf1a83/COC1C2C%255BC%2540H%255D3C%2528C%2529%2528C%2529O%255BC%2540%2540%255D%2528C%255CC%253DC%2528%252FCO%2529C%2528O%2529%253DO%2529%2528C2%253DO%2529%255BC%2540%255D32Oc3c%2528CC%253DC%2528C%2529C%2529c4OC%2528C%2529%2528CCC%253DC%2528C%2529C%2529C%253DCc4c%2528O%2529c3C%2528%253DO%2529%255BC%2540H%255D12.png)
![Chemical structure of (2Z)-4-[12-hydroxy-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11,15-pentaen-19-yl]-2-methylbut-2-enoic acid - CSSB00116206874](/st/structure/200/17601d51ed39db3e3d3dc3eb26dd9a1e/CC%2528C%2529%253DCCCC1%2528C%2529OC2%253DC%2528CC%253DC%2528C%2529C%2529C3%253DC%2528C%2528O%2529%253DC2C%253DC1%2529C%2528%253DO%2529C1%253DCC2CC4C%2528C%2529%2528C%2529OC%2528C%255CC%253DC%2528%255CC%2529C%2528O%2529%253DO%2529%2528C2%253DO%2529C14O3.png)
![Chemical structure of 4-[12-hydroxy-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11,15-pentaen-19-yl]-2-methylbut-2-enoic acid - CSSB02125605636](/st/structure/200/1be8851a776648990bca28392e9886cf/CC%2528C%2529%253DCCCC1%2528C%2529OC2%253DC%2528CC%253DC%2528C%2529C%2529C3%253DC%2528C%2528O%2529%253DC2C%253DC1%2529C%2528%253DO%2529C1%253DCC2CC4C%2528C%2529%2528C%2529OC%2528CC%253DC%2528C%2529C%2528O%2529%253DO%2529%2528C2%253DO%2529C14O3.png)
![Chemical structure of (2Z)-4-[(1S,2S,8S,19R)-12-hydroxy-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11,15-pentaen-19-yl]-2-methylbut-2-enoic acid - CSSB06744481978](/st/structure/200/b12b78ab5611008adb234d2913acec68/CC%2528C%2529%253DCCC%255BC%2540%255D1%2528C%2529Oc2c%2528CC%253DC%2528C%2529C%2529c3O%255BC%2540%2540%255D45%255BC%2540H%255D6CC%2528C%253DC4C%2528%253DO%2529c3c%2528O%2529c2C%253DC1%2529C%2528%253DO%2529%255BC%2540%255D5%2528C%255CC%253DC%2528%255CC%2529C%2528O%2529%253DO%2529OC6%2528C%2529C.png)
![Chemical structure of (2Z)-4-[(1S,2S,8R,17S,19R)-12-hydroxy-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11,15-pentaen-19-yl]-2-methylbut-2-enoic acid - CSSB00016992624](/st/structure/200/c6606eba2c13c906f5201d575c8e3800/CC%2528C%2529%253DCCC%255BC%2540%2540%255D1%2528C%2529OC2%253DC%2528CC%253DC%2528C%2529C%2529C3%253DC%2528C%2528O%2529%253DC2C%253DC1%2529C%2528%253DO%2529C1%253DC%255BC%2540%2540H%255D2C%255BC%2540H%255D4C%2528C%2529%2528C%2529O%255BC%2540%2540%255D%2528C%255CC%253DC%2528%255CC%2529C%2528O%2529%253DO%2529%2528C2%253DO%2529%255BC%2540%2540%255D14O3.png)
